Alto Neuroscience Inc (NYSE: ANRO) on Friday, soared 3.41% from the previous trading day, before settling in for the closing price of $2.93. Within the past 52 weeks, ANRO’s price has moved between $1.60 and $17.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -33.33% over the past five years. The company achieved an average annual earnings per share of 1.07%. With a float of $21.49 million, this company’s outstanding shares have now reached $27.07 million.
Let’s look at the performance matrix of the company that is accounted for 76 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Alto Neuroscience Inc (ANRO) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Alto Neuroscience Inc is 20.61%, while institutional ownership is 76.53%. The most recent insider transaction that took place on Jul 09 ’24, was worth 152,085. In this transaction CHIEF MEDICAL OFFICER of this company bought 12,069 shares at a rate of $12.60, taking the stock ownership to the 36,920 shares. Before that another transaction happened on Jul 10 ’24, when Company’s CHIEF MEDICAL OFFICER bought 2,931 for $13.22, making the entire transaction worth $38,748. This insider now owns 39,851 shares in total.
Alto Neuroscience Inc (ANRO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 1.07% per share during the next fiscal year.
Alto Neuroscience Inc (NYSE: ANRO) Trading Performance Indicators
Alto Neuroscience Inc (ANRO) is currently performing well based on its current performance indicators. A quick ratio of 22.53 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.34, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -2.76 in one year’s time.
Technical Analysis of Alto Neuroscience Inc (ANRO)
Alto Neuroscience Inc (NYSE: ANRO) saw its 5-day average volume 0.22 million, a negative change from its year-to-date volume of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 90.84%. Additionally, its Average True Range was 0.19.
During the past 100 days, Alto Neuroscience Inc’s (ANRO) raw stochastic average was set at 43.60%, which indicates a significant decrease from 94.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.69% in the past 14 days, which was lower than the 89.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.40, while its 200-day Moving Average is $5.74. Nevertheless, the first resistance level for the watch stands at $3.11 in the near term. At $3.19, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.29. If the price goes on to break the first support level at $2.92, it is likely to go to the next support level at $2.82. Assuming the price breaks the second support level, the third support level stands at $2.74.
Alto Neuroscience Inc (NYSE: ANRO) Key Stats
Market capitalization of the company is 82.03 million based on 27,072K outstanding shares. Right now, sales total 0 K and income totals -61,430 K. The company made 0 K in profit during its latest quarter, and -15,170 K in sales during its previous quarter.
